Skip to main content
    D

    DaVita HealthCare Partners Inc (DVA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $174.14
    -0.42 (-0.24%)

    Market Cap: $10.98B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    DaVita HealthCare Partners Inc (DVA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect DaVita HealthCare Partners (DVA) to earn $14.70 per share in the fiscal year ending Dec 31, 2026, on revenue of $14.25B. Of 8 analysts, 3 rate the stock Buy or Strong Buy, 4 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.88, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 38% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy337.5%
    Hold450.0%
    Sell00.0%
    Strong Sell112.5%
    Consensus
    Hold
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 14.8% and revenue estimates rise 3.5%.

    Fiscal year ending Dec 31, 2026
    $14.70
    EPS consensus, revenue $14.25B
    Fiscal year ending Dec 31, 2027
    $16.88
    EPS consensus, revenue $14.75B
    Next report
    Feb 1, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$14.70$14.34 to $14.986$14.25B$14.18B to $14.50B6
    Dec 31, 2027$16.88$16.33 to $18.418$14.75B$14.51B to $15.28B7

    Quarterly Estimates

    The EPS consensus falls from $4.19 for the quarter ending Dec 31, 2026 to $3.30 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$4.19$3.92 to $4.568$3.69B$3.56B to $3.86B7
    Mar 31, 2027$3.30$3.15 to $3.533$3.52B$3.51B to $3.54B2

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 9 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202623
    Fiscal year ending Dec 31, 202705
    Quarter ending Mar 31, 202711

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 1.0% from $14.85.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$14.70$14.70$14.82$14.85$14.85-1.0%
    Fiscal year ending Dec 31, 2027$16.88$16.87$17.14$17.25$17.02-0.8%
    Quarter ending Mar 31, 2027$3.30$3.30$3.31$3.33$3.26+1.3%

    Frequently Asked Questions About DVA

    What is the DVA stock forecast?

    Consensus analyst estimates put DaVita HealthCare Partners's EPS at $14.70 for the fiscal year ending Dec 31, 2026, on revenue of $14.25B. The consensus rating from 8 analysts is Hold.

    How do analysts rate DVA stock?

    Of 8 analysts covering DaVita HealthCare Partners, 0 rate it Strong Buy, 3 Buy, 4 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from DVA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $14.70, with estimates from $14.34 to $14.98 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $16.88, with estimates from $16.33 to $18.41 from 8 analysts.

    What revenue do analysts expect from DaVita HealthCare Partners next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $14.25B, with estimates from $14.18B to $14.50B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $14.75B, with estimates from $14.51B to $15.28B.

    How many analysts cover DVA?

    8 analysts rate DaVita HealthCare Partners stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.